Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 06:00:02 22/08/26 am AEST			5-day change	1st Jan Change
380.03 ^USD	+0.95%		+6.67%	+25.43%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	10.09B	BBB	-
ABBOTT LABORATORIES	202B	BBB
MEDTRONIC PLC	119B	BBB
CENCORA, INC.	60.69B	AA
HOYA CORPORATION	52.38B	AAA
BECTON, DICKINSON AND COMPANY	52.3B	A
DEXCOM, INC.	34.85B	BBB
MEDLINE INC.	30.06B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.85B	AA
TERUMO CORPORATION	23.84B	AA
STERIS PLC	23.2B	AAA	-
SARTORIUS STEDIM BIOTECH	21.98B	BBB
ZIMMER BIOMET HOLDINGS, INC.	19.26B	A
SOLVENTUM CORPORATION	15.25B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.27B	A
BAXTER INTERNATIONAL INC.	13.62B	A
GLOBUS MEDICAL, INC.	11.67B	CCC
ALIGN TECHNOLOGY, INC.	11.55B	A
INSULET CORPORATION	10.28B	A
REPLIGEN CORPORATION	10.22B	AA
Average	38.13B	A
Weighted average by Cap.		A